David Li
Lawyers
Associate in our Capital Markets practice.
David advises U.S. and non-U.S. companies and investment banks on capital markets transactions, including initial public offerings, follow-on equity offerings and investment-grade and high-yield debt offerings. His practice ranges across a variety of industries, with particular focus on biotech and technology.
Experience highlights
Recent Representations
- Immatics $110 million follow-on offering
- Alignment Healthcare $132.75 million secondary offering
- ADC Therapeutics $175 million term loan facility and other financings
- Canada $3.5 billion global bond offering
- Excelerate Energy $384 million IPO
- Gates Industrial $87.1 million secondary offering
- Advance Auto Parts $350 million notes offering
- Gates Industrial $460 million secondary offering
- SOPHiA GENETICS $234 million IPO and $20 million private placement
- Province of British Columbia $2.5 billion global bond offering
- Gatos Silver $160 million follow-on offering
- XPO Logistics $794 million follow-on and secondary offering
- Ayala Pharmaceuticals $20 million at-the-market offering
- Canada $3.5 billion global bond offering
- Masco $1.5 billion notes offering
- InflaRx $75 million follow-on offering
Education
J.D., Harvard Law School
- magna cum laude
- Senior Editor, Harvard Law Review
B.Sc., Psychology, University of Toronto
Professional history
- Davis Polk since 2018
Qualifications and admissions
- State of New York